B. Franke, Netherlands

Radboudumc Department of Human Genetics, route 855
Barbara Franke is full professor of Molecular Psychiatry at Radboud University in Nijmegen, based at the Human Genetics and Psychiatry departments of Radboudumc. She is also Principal Investigator at the Donders Institute for Brain, Cognition and Behaviour. At Radboudumc, she chairs the Division of Genome Research and the Radboud Research Theme Neurodevelopmental Disorders. She is an elected member of the Royal Netherlands Academy of Arts and Sciences (KNAW), the Royal Holland Society of Sciences and Humanities (KHMW), and Academia Europaea. Educated in Giessen (Germany) and Utrecht (The Netherlands), she obtained her PhD in molecular signal-transduction in Utrecht before joining Radboud University. Her research focuses on understanding the genetic contribution to neurodevelopmental psychiatric disorders and traits, especially externalizing phenotypes. Beyond gene finding, she uses complementary approaches (bioinformatics, i-neurons, small animal models, neuroimaging genetics) to map biological pathways from gene to disease. She has obtained prestigious grants, including a personal NWO Vici grant and several EU consortium grants. International collaborative research is a great motivator for her; she founded and coordinates the International Multicentre persistent ADHD Collaboration (IMpACT) and the ECNP Network “ADHD across the Lifespan”, is a co-founder of the neuroimaging genetics consortium ENIGMA, and leads ENIGMA’s ADHD Working Group and the Psychiatric Genomics Consortium’s ADHD Working Group. In 2018, she was elected as a member of the Board of Directors of the International Society of Psychiatric Genetics (ISPG). Since 2019, she holds Honorary Professorships at Goethe University, Frankfurt am Main, Germany and Aarhus University, Aarhus, Denmark.

Moderator Of 1 Session

EPA Course
Date
Sat, 10.04.2021
Session Time
14:00 - 16:00
Room
Courses Hall A
Session Description
Attention-Deficit/Hyperactivity Disorder (ADHD) is a chronic neurodevelopmental disorder that is characterized by attentional problems, deficient impulse control, hyperactivity and often also by emotional dysregulation. ADHD has its onset in childhood and affects approximately 5% of children. In over half of the individuals with ADHD, symptoms persist into adulthood and even old age. World-wide, ADHD in adulthood is under-recognised and under-treated. Undiagnosed or untreated ADHD in adulthood is problematic, because it often co-occurs with other psychiatric and somatic illnesses. Among the most prevalent ones are major depression, anxiety, substance use and obesity. These comorbid conditions considerably contribute to the disease burden of individuals, as well as to healthcare costs. In many instances, individuals with ADHD drop out of psychiatric healthcare in the transition from childhood to adult services. Later in life, they often return with symptoms of comorbid conditions; their ADHD often is not recognised at that point and there is a danger that they might receive treatments for their comorbid problems without awareness and adequate care for the underlying ADHD. Providing care throughout the lifespan, but especially in young adults, may therefore be pivotal to reducing this negative developmental trajectory later in life. In this course, experts in adult ADHD will inform clinical psychiatrists about the prevalence and characteristics of ADHD in adulthood and its most common comorbid conditions across the lifespan. Using real life examples of cases, participants will practice how to diagnose ADHD in the context of comorbidity, and discuss different (pharmacological and non-pharmacological) treatment and psychotherapy options.
Session Icon
Live, Ticket Required

Presenter Of 1 Presentation

Course 01: Comorbidities of ADHD Across the Lifespan (ID 64) No Topic Needed

Comorbidities of ADHD Across the Lifespan

Session Icon
Live, Ticket Required
Date
Sat, 10.04.2021
Session Time
14:00 - 16:00
Room
Courses Hall A
Lecture Time
14:00 - 16:00